人工智能能否替代超声作为乳腺X线摄影的辅助工具诊断乳腺癌
该前瞻性研究纳入2000例乳腺X线摄影,所有病例均行超声检查,AI以热图和异常评分百分比评估乳腺病灶,以手术和病理为参考标准。AI异常评分59%时鉴别乳腺病灶的敏感度96.8%、特异度90.1%,作者认为AI可作为乳腺X线摄影的可靠辅助工具,联合使用可区分需进一步成像或活检与仅需随访的病例。
要点
- AI异常评分59%时鉴别乳腺病灶敏感度96.8%、特异度90.1%。
- BI-RADS 2病灶AI异常评分中位数10%,BI-RADS 5病灶中位数88%。
- AI联合乳腺X线摄影有望作为一站式方法区分需进一步成像或活检与仅随访者。
核心结论
- AI可作为数字乳腺X线摄影的可靠辅助工具用于乳腺病灶评估。
- AI的颜色色调和异常评分百分比在乳腺癌检测与鉴别上接近超声的准确性。
- AI-乳腺X线摄影联合可作为一站式方法区分需进一步成像或活检与仅需时间间隔随访的病例。
研究设计与样本
- 前瞻性分析,经伦理委员会批准。
- 研究纳入2000例乳腺X线摄影,所有病例均行乳腺超声。
- 由放射科医生解读乳腺X线摄影,并联合乳腺X线摄影与超声评估应用BI-RADS评分。
- 每侧乳腺单独借助AI扫描以靶向热图形式评估,获得恶性概率(异常评分百分比)。
- 以手术和组织病理学数据为标准参考。
关键影像表现/征象
- BI-RADS 1且无病灶的正常病例被排除出统计分析。
- 研究纳入538个良性乳腺病灶和642个恶性乳腺病灶(n=1180,59%)。
- 联合评估数字乳腺X线摄影与超声,385个病灶(385/1180,32.6%)为BI-RADS 2(良性),其AI异常评分百分比中位数为10。
- 471个病灶(471/1180,39.9%)为BI-RADS 5(恶性),其AI异常评分百分比中位数为88。
诊断标准与关键数值
- AI异常评分59%时,鉴别纳入乳腺X线摄影所检出乳腺病灶的敏感度为96.8%、特异度为90.1%。
- BI-RADS 2(良性)385个病灶的AI异常评分百分比中位数为10。
- BI-RADS 5(恶性)471个病灶的AI异常评分百分比中位数为88。
临床应用与阅片要点
- AI异常评分百分比可作为乳腺X线摄影检出病灶的定量辅助指标,59%可作为鉴别良恶性的参考阈值。
- AI热图的颜色色调可提供定性评估信息,与异常评分百分比结合使用。
- AI-乳腺X线摄影联合有望减少不必要的进一步成像或活检,并识别仅需时间间隔随访的病例。
局限性
- 原文未明确报告研究局限性。
- 本研究为单中心前瞻性分析,结果的外推性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To study the impact of artificial intelligence (AI) on the performance of mammogram with regard to the classification of the detected breast lesions in correlation to ultrasound-aided mammograms.
METHODS: Ethics committee approval was obtained in this prospective analysis. The study included 2000 mammograms. The mammograms were interpreted by the radiologists and breast ultrasound was performed for all cases. The Breast Imaging Reporting and Data System (BI-RADS) score was applied regarding the combined evaluation of the mammogram and the ultrasound modalities. Each breast side was individually assessed with the aid of AI scanning in the form of targeted heat-map and then, a probability of malignancy (abnormality scoring percentage) was obtained. Operative and the histopathology data were the standard of reference.
RESULTS: Normal assigned cases (BI-RADS 1) with no lesions were excluded from the statistical evaluation. The study included 538 benign and 642 malignant breast lesions (n = 1180, 59%). BI-RADS categories for the breast lesions with regard to the combined evaluation of the digital mammogram and ultrasound were assigned BI-RADS 2 (Benign) in 385 lesions with AI median value of the abnormality scoring percentage of 10 (n = 385/1180, 32.6%), and BI-RADS 5 (malignant) in 471, that had showed median percentage AI value of 88 (n = 471/1180, 39.9%). AI abnormality scoring of 59% yielded a sensitivity of 96.8% and specificity of 90.1% in the discrimination of the breast lesions detected on the included mammograms.
CONCLUSION: AI could be considered as an optional primary reliable complementary tool to the digital mammogram for the evaluation of the breast lesions. The color hue and the abnormality scoring percentage presented a credible method for the detection and discrimination of breast cancer of near accuracy to the breast ultrasound. So consequently, AI- mammogram combination could be used as a one setting method to discriminate between cases that require further imaging or biopsy from those that need only time interval follows up.
ADVANCES IN KNOWLEDGE: Recently, the indulgence of AI in the work-up of breast cancer was concerned. AI noted as a screening strategy for the detection of breast cancer. In the current work, the performance of AI was studied with regard to the diagnosis not just the detection of breast cancer in the mammographic-detected breast lesions. The evaluation was concerned with AI as a possible complementary reading tool to mammogram and included the qualitative assessment of the color hue and the quantitative integration of the abnormality scoring percentage.
引用
- Mansour S, Kamal R, Hashem L, et al. Can artificial intelligence replace ultrasound as a complementary tool to mammogram for the diagnosis of the breast cancer? Br J Radiol. 2021. PMID: 34613796. doi:10.1259/bjr.20210820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。